Skip to content

The Effect of Releasing the Tourniquet in Total Knee Replacement Before Closure on the Blood Loss , Joint Effusion , Hematoma Formation and Wound Complication

The Effect of Releasing the Tourniquet in Total Knee Replacement Before Closure on the Blood Loss , Joint Effusion , Hematoma Formation and Wound Complication

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04810000
Enrollment
113
Registered
2021-03-22
Start date
2018-12-03
Completion date
2021-03-01
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Hematoma

Keywords

Tourniquet, Intra articular Hematoma, Total Knee Replacement

Brief summary

The study , observe the effect of releasing the Tourniquet in total knee replacement surgery before closure in comparison with releasing it after wound closure The effect was assessed by Hb drop post operative and Hematoma formation ( measured by ultrasound ) as well as the wound complication

Detailed description

The study is conducted in tertiary university hospital as a referral hospital for joint arthroplasty , the patients was informed about the study and consent was taken , the same operator , same theater and the same prosthesis company as well as the same radiologist during the study period. the patient randomly assigned to either group A (Tourniquet release before closure of the wound and hemostasis ensured ) , or a group B ( Tourniquet release after wound closure ) post operative Hb drop was studied between the groups , and each patient underwent ultrasound measurement of the intraarticular hematoma . The wound complication between the groups was also studied .

Interventions

DEVICEtourniquet

Tourniquet release before/after wound closure

Sponsors

Yazan Saleh Rajab Hammad
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* primary knee osteoarthrosis

Exclusion criteria

* Rheumatoid arthritis * post traumatic arthritis * revision knee replacement * patients on anticoagulant/antiplatelet except acetylsalicylic acid 80-100 mg

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin(HG) drop( pre-operative and post-operative day 2)The difference in HG drop
Intra articular Hematoma formationday three post operative hematoma formationthe difference in Intra articular ( knee ) Hematoma collection between the groups on day 3 post operative

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026